iQone is a Swiss specialty pharma company for oncology, immunology and rare diseases. We commercialise innovative and biosimilar medicines with 7 marketed and 9 late-stage products. iQone can support partner products directly in the 5 major EU + CH markets, and indirectly in the rest of Europe.
- Agility and speed of decision-making
- Pragmatism while delivering excellence
- High quality portfolio/pipeline boosting patient access to medicines for high unmet needs
What are the core strengths of your current team and what skills are you looking forward to integrate in the future?
Key strengths and skills that iQone currently focuses on and will continue to, are: